KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Revenue (2016 - 2025)

Historic Revenue for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $708.4 million.

  • Medpace Holdings' Revenue rose 3202.84% to $708.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year increase of 1997.01%. This contributed to the annual value of $2.5 billion for FY2025, which is 1997.01% up from last year.
  • Latest data reveals that Medpace Holdings reported Revenue of $708.4 million as of Q4 2025, which was up 3202.84% from $659.9 million recorded in Q3 2025.
  • Medpace Holdings' 5-year Revenue high stood at $708.4 million for Q4 2025, and its period low was $260.0 million during Q1 2021.
  • In the last 5 years, Medpace Holdings' Revenue had a median value of $476.7 million in 2023 and averaged $456.4 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 3575.6% in 2021, then surged by 766.21% in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Revenue stood at $308.6 million in 2021, then grew by 27.72% to $394.1 million in 2022, then increased by 26.47% to $498.4 million in 2023, then grew by 7.66% to $536.6 million in 2024, then surged by 32.03% to $708.4 million in 2025.
  • Its Revenue stands at $708.4 million for Q4 2025, versus $659.9 million for Q3 2025 and $603.3 million for Q2 2025.